San Francisco, CA --Biosensors International Group, Ltd. ("Biosensors") has announced final results of the AXXESS PLUS trial, which demonstrated the long-term efficacy and safety of the Axxessâ„¢ stent ...
Paris, France, New long-term data from the DIVERGE study, presented yesterday at EuroPCR 2011, showed that the use of the Axxessâ„¢ DES for the treatment of complex coronary bifurcation lesions resulted ...